Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biote (BTMD) EBT Margin (2021 - 2025)

Biote (BTMD) has 3 years of EBT Margin data on record, last reported at 12.36% in Q4 2023.

  • For Q4 2023, EBT Margin rose 12007.0% year-over-year to 12.36%; the TTM value through Dec 2023 reached 2.14%, up 7314.0%, while the annual FY2024 figure was 0.16%, 7.0% up from the prior year.
  • EBT Margin reached 12.36% in Q4 2023 per BTMD's latest filing, down from 13.32% in the prior quarter.
  • Across five years, EBT Margin topped out at 40.11% in Q4 2021 and bottomed at 208.9% in Q2 2022.
  • Average EBT Margin over 3 years is 18.84%, with a median of 12.36% recorded in 2023.
  • Peak YoY movement for EBT Margin: plummeted -23721bps in 2022, then soared 21929bps in 2023.
  • A 3-year view of EBT Margin shows it stood at 40.11% in 2021, then tumbled by -369bps to 107.71% in 2022, then skyrocketed by 111bps to 12.36% in 2023.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 12.36% in Q4 2023, 13.32% in Q3 2023, and 10.4% in Q2 2023.